ID: ALA3809783

Max Phase: Preclinical

Molecular Formula: C22H20N2O3

Molecular Weight: 360.41

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1ccc2[nH]cc(C(=O)C(=O)CCCc3c[nH]c4ccccc34)c2c1

Standard InChI:  InChI=1S/C22H20N2O3/c1-27-15-9-10-20-17(11-15)18(13-24-20)22(26)21(25)8-4-5-14-12-23-19-7-3-2-6-16(14)19/h2-3,6-7,9-13,23-24H,4-5,8H2,1H3

Standard InChI Key:  NRIAUEWTAVIVLL-UHFFFAOYSA-N

Associated Targets(Human)

HeLa 62764 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

MDA-MB-231 73002 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Pseudomonas putida 467 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Escherichia coli 133304 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Klebsiella pneumoniae 43867 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 360.41Molecular Weight (Monoisotopic): 360.1474AlogP: 4.43#Rotatable Bonds: 7
Polar Surface Area: 74.95Molecular Species: NEUTRALHBA: 3HBD: 2
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 12.80CX Basic pKa: CX LogP: 4.58CX LogD: 4.58
Aromatic Rings: 4Heavy Atoms: 27QED Weighted: 0.38Np Likeness Score: -0.10

References

1. Tantak MP, Gupta V, Nikhil K, Arun V, Singh RP, Jha PN, Shah K, Kumar D..  (2016)  Sequential one-pot synthesis of bis(indolyl)glyoxylamides: Evaluation of antibacterial and anticancer activities.,  26  (13): [PMID:27173802] [10.1016/j.bmcl.2016.04.080]

Source